![Randall Kaye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Randall Kaye
Director/Board Member at
NERVGEN PHARMA CORP.
Net worth: 331 200 $ as of 30/05/2026
Profile
Randall E.
Kaye is an Independent Non-Executive Director at NervGen Pharma Corp.
since 2020.
Former roles include Vice President-Medical Affairs at Scios, Inc. from 2004 to 2006; Chief Medical Officer & SVP-Medical Affairs at Avanir Pharmaceuticals, Inc. from 2013 to 2014; Vice President-Medical Affairs at InterMune, Inc.; Chief Medical Officer at Axsome Therapeutics, Inc. from 2014 to 2016; Chief Medical Officer at Click Therapeutics, Inc. from 2018 to 2019; Chief Medical Officer & EVP at Longboard Pharmaceuticals, Inc.; Chief Scientific Officer at SSI Strategy LLC from 2014 to 2018; and Chief Medical Officer at Neurana Pharmaceuticals, Inc. Education includes undergraduate, graduate, and doctorate degrees from George Washington University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/01/2026 | 160,000 ( 0.2% ) | 331 200 $ | 30/05/2026 |
Randall Kaye active positions
| Companies | Position | Start |
|---|---|---|
| NERVGEN PHARMA CORP. | Director/Board Member | 27/10/2020 |
Former positions of Randall Kaye
| Companies | Position | End |
|---|---|---|
Click Therapeutics, Inc.
 Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Chief Tech/Sci/R&D Officer | 31/08/2019 |
SSI Strategy LLC
 SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services Provides bio-tech sciences consulting services | Corporate Officer/Principal | 31/08/2018 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2016 |
| AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 31/08/2014 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Chief Tech/Sci/R&D Officer | 31/12/2005 |
Training of Randall Kaye
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Technology Services |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services Provides bio-tech sciences consulting services | Commercial Services |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
- Stock Market
- Insiders
- Randall Kaye
